Filed: 5/14/2026ACC: 0002081668-26-000006
📋 What this filing means
ROYALTY PHARMA SUB-MANAGER, LLC filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $172.76M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$172.76M
Total AUM (reported)
10.15M
Total Shares
Allocation by class
COM$172.76M100.0%
Portfolio Concentration
Top 3$147.92M85.6%
4–10$24.84M14.4%
Top 3 weight
85.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 10.15M
Sole
Full voting authority
10.15M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other4
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
CYTOKINETICS, INC
DFNDShares980.39K
TypeSH
Market value$64.62M
37.40%
Sole
980.39K
Shared
0.00
None
0.00
ZENAS BIOPHARMA, INC.
DFNDShares2.39M
TypeSH
Market value$46.69M
27.02%
Sole
2.39M
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
DFNDShares3.85M
TypeSH
Market value$36.62M
21.19%
Sole
3.85M
Shared
0.00
None
0.00
BIOHAVEN LTD
DFNDShares2.94M
TypeSH
Market value$24.84M
14.38%
Sole
2.94M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CYTOKINETICS, INCDFND | COM | 980.39K | SH | $64.62M 37.40% | 980.39K | 0.00 | 0.00 |
ZENAS BIOPHARMA, INC.DFND | COM | 2.39M | SH | $46.69M 27.02% | 2.39M | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCDFND | COM | 3.85M | SH | $36.62M 21.19% | 3.85M | 0.00 | 0.00 |
BIOHAVEN LTDDFND | COM | 2.94M | SH | $24.84M 14.38% | 2.94M | 0.00 | 0.00 |